Ambalal Sarabhai Enterprises Limited (BOM:500009)
India · Delayed Price · Currency is INR 25.12
-1.11 (-4.23%)
At close: Mar 27, 2026
BOM:500009 Revenue
Ambalal Sarabhai Enterprises had revenue of 519.96M INR in the quarter ending December 31, 2025, with 13.11% growth. This brings the company's revenue in the last twelve months to 2.03B, up 8.72% year-over-year. In the fiscal year ending March 31, 2025, Ambalal Sarabhai Enterprises had annual revenue of 1.97B with 13.20% growth.
Revenue (ttm)
2.03B
Revenue Growth
+8.72%
P/S Ratio
0.95
Revenue / Employee
3.71M
Employees
104
Market Cap
1.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.97B | 230.03M | 13.20% |
| Mar 31, 2024 | 1.74B | 32.87M | 1.92% |
| Mar 31, 2023 | 1.71B | -266.02M | -13.46% |
| Mar 31, 2022 | 1.98B | 324.75M | 19.66% |
| Mar 31, 2021 | 1.65B | 316.72M | 23.72% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medico Remedies | 1.91B |
| Everest Organics | 1.89B |
| Sat Kartar Life | 1.63B |
| Gennex Laboratories | 1.52B |
| Aayush Wellness | 1.29B |
| Kerala Ayurveda | 1.27B |
| Trident Lifeline | 1.27B |
| Astonea Labs | 1.17B |
Ambalal Sarabhai Enterprises News
- 7 days ago - EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - Benzinga